You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

DFMO

Showing 1 - 25 of 33
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Cancer, Solid Tumor, Solid Carcinoma Trial in United States (AMXT1501, DFMO)

Active, not recruiting
  • Cancer
  • +3 more
  • Austin, Texas
  • +3 more
Jan 18, 2023

Glioblastoma, IDH-wildtype, Glioblastoma, Glioblastoma Multiforme Trial in Cleveland (Eflornithine (Dose Level 1), Eflornithine

Recruiting
  • Glioblastoma, IDH-wildtype
  • +4 more
  • Eflornithine (Dose Level 1)
  • +3 more
  • Cleveland, Ohio
    The Cleveland Clinic
May 19, 2023

Diffuse Glioma, Malignant Glioma Trial in Rochester (Biospecimen Collection, Computed Tomography, Eflornithine)

Not yet recruiting
  • Diffuse Glioma
  • Malignant Glioma
  • Biospecimen Collection
  • +6 more
  • Rochester, Minnesota
    Mayo Clinic in Rochester
Feb 6, 2023

Neuroblastoma, Medulloblastoma, Typical Teratoid Rhabdoid Tumor Trial in Charlotte (eflornithine HCl)

No longer available
  • Neuroblastoma
  • +5 more
  • eflornithine HCl
  • Charlotte, North Carolina
    Levine Children's Hospital
Apr 20, 2022

Cancer, Solid Tumor, Solid Carcinoma Trial in Houston (AMXT1501, DFMO)

Recruiting
  • Cancer
  • +18 more
  • Houston, Texas
    MD Anderson Cancer Center
Aug 12, 2022

Non-melanoma Skin Cancer Trial in Birmingham (Solaraze and Vaniqa)

Recruiting
  • Non-melanoma Skin Cancer
  • Solaraze and Vaniqa
  • Birmingham, Alabama
  • +1 more
Nov 14, 2022

Neuroblastoma Trial in Australia, Canada, United States (DFMO, Celecoxib, Cyclophosphamide)

Active, not recruiting
  • Neuroblastoma
  • DFMO
  • +3 more
  • Los Angeles, California
  • +12 more
Jan 30, 2023

Medulloblastoma Trial in United States (Difluoromethylornithine)

Recruiting
  • Medulloblastoma
  • Little Rock, Arkansas
  • +12 more
Aug 3, 2022

Neuroblastoma Trial in Canada, United States (Eflornithine)

Recruiting
  • Neuroblastoma
  • Little Rock, Arkansas
  • +22 more
Jan 23, 2023

Type 1 Diabetes Trial in United States (DFMO, Placebo)

Not yet recruiting
  • Type 1 Diabetes
  • DFMO
  • Placebo
  • Aurora, Colorado
  • +5 more
Oct 21, 2022

Neuroblastoma Trial in United States (DFMO)

Active, not recruiting
Has Results
  • Neuroblastoma
  • DFMO
  • Phoenix, Arizona
  • +21 more
Jan 25, 2023

Prostate Cancer Trial in Baltimore (DFMO, testosterone cypionate, Luteinizing hormone-releasing hormone (LHRH) analogue)

Not yet recruiting
  • Prostate Cancer
  • DFMO
  • +3 more
  • Baltimore, Maryland
    Johns Hopkins University: Sidney Kimmel Comprehensive Cancer Cen
Sep 22, 2023

Neuroblastoma Trial in United States (Ceritinib, dasatinib, sorafenib)

Recruiting
  • Neuroblastoma
  • Birmingham, Alabama
  • +23 more
Sep 26, 2022

Type 1 Diabetes Trial in Indianapolis, Buffalo, Wauwatosa (Difluoromethylornithine, Placebo)

Completed
  • Type 1 Diabetes
  • Indianapolis, Indiana
  • +2 more
Sep 3, 2021

Neuroblastoma Trial in United States (DFMO)

Active, not recruiting
  • Neuroblastoma
  • DFMO
  • Phoenix, Arizona
  • +17 more
Nov 16, 2020

Gastric Cancer, Gastric Intestinal Metaplasia Trial in Copán, San Juan (Eflornithine, Eflornithine )

Active, not recruiting
  • Gastric Cancer
  • Gastric Intestinal Metaplasia
  • Copán, Honduras
  • +1 more
Aug 17, 2022

Colorectal Cancer, Familial Adenomatous Polyposis Trial in Houston (Celecoxib, Placebo, eflornithine)

Completed
Has Results
  • Colorectal Cancer
  • Familial Adenomatous Polyposis
  • Houston, Texas
    M D Anderson Cancer Center
Sep 8, 2020

Post-solid Organ Transplant, Skin Tumors Trial (Difluoromethylornithine)

Completed
  • Post-solid Organ Transplant
  • Skin Neoplasms
  • (no location specified)
Dec 12, 2019

Non-melanomatous Skin Cancer Trial (eflornithine)

Completed
  • Non-melanomatous Skin Cancer
  • (no location specified)
Dec 12, 2019

Adenomatous Polyp Trial in Chicago, Rochester (Aspirin, Eflornithine, Laboratory Biomarker Analysis)

Completed
Has Results
  • Adenomatous Polyp
  • Chicago, Illinois
  • +2 more
Aug 23, 2019

Non-melanoma Skin Cancer Trial in Birmingham (topical diclofenac daily, )

Active, not recruiting
  • Non-melanoma Skin Cancer
  • topical diclofenac daily
  • placebo
  • Birmingham, Alabama
    University of Alabama at Birmingham Whitaker Clinic
Feb 22, 2022

High Risk Neuroblastoma, Recurrent Neuroblastoma, Refractory Neuroblastoma Trial in Worldwide (Dinutuximab, Eflornithine

Recruiting
  • High Risk Neuroblastoma
  • +2 more
  • Dinutuximab
  • +4 more
  • Birmingham, Alabama
  • +141 more
Dec 28, 2022

Anaplastic Astrocytoma, Recurrent Anaplastic Astrocytoma Trial in Worldwide (Eflornithine, Lomustine)

Active, not recruiting
  • Anaplastic Astrocytoma
  • Recurrent Anaplastic Astrocytoma
  • Birmingham, Alabama
  • +78 more
Jan 19, 2022

Hearing Impairment Trial in Chiayi City (Placebo, Pomegranate)

Completed
  • Hearing Impairment
  • Placebo
  • Pomegranate
  • Chiayi City, Taiwan
    Dalin Tzu Chi Hospital
Mar 22, 2022

Cervical Cancer, Precancerous Condition Trial in Houston (Eflornithine, Placebo)

Completed
  • Cervical Cancer
  • Precancerous Condition
  • Houston, Texas
    University of Texas - MD Anderson Cancer Center
Oct 24, 2018